Pregabalin controlled-release pharmacokinetics in healthy volunteers: Analysis of four multiple-dose randomized clinical pharmacology studies

Clinical Drug Investigation

Volumn 34, Issue 9, 2014, Pages 627-637

  Chew, Marci L ^a   Alvey, Christine W ^a   Plotka, Anna ^a   Pitman, Verne W ^a   Alebic Kolbah, Tanja ^a   Scavone, Joseph M ^a   Bockbrader, Howard N ^b  

^a PFIZER INC   (United States)

^b BEP Analyses   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREGABALIN; 4 AMINOBUTYRIC ACID; ANALGESIC AGENT; DELAYED RELEASE FORMULATION; TABLET;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERSOMNIA; IMMEDIATE RELEASE FORMULATION; MALE; MULTIPLE DRUG DOSE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TABLET FORMULATION; ANALOGS AND DERIVATIVES; BIOAVAILABILITY; CLINICAL TRIAL; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DOSE RESPONSE; DRUG ADMINISTRATION; FOOD; MIDDLE AGED; TABLET; THERAPEUTIC EQUIVALENCE; YOUNG ADULT;

ADULT; ANALGESICS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOOD; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; TABLETS; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 84906939578     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.1007/s40261-014-0221-2     Document Type: Article

References (25)

1. Lyrica (pregabalin) [package insert]. New York: Pfizer Inc.; 2013. http://labeling.pfizer.com/ShowLabeling.aspx?id=561. Accessed 18 July 2014.
2. Lyrica EU product information. Sandwich: Pfizer Limited; 2014. http://www.emea.europa.eu/docs/en-GB/document-library/EPAR---Product- Information/human/000546/WC500046602.pdf. Accessed 18 July 2014.
3. Corrigan BW, Pool WF, Posvar EL, et al. Metabolic disposition of pregabalin in healthy volunteers [abstract PI-68]. Clin Pharmacol Ther. 2001;69:P18.
4. Bockbrader HN, Radulovic LL, Posvar EL, et al. Clinical pharmacokinetics of pregabalin in healthy volunteers. J Clin Pharmacol. 2010;50:941-50.
5. Randinitis EJ, Posvar EL, Alvey CW, et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol. 2003;43:277-83.
6. Bockbrader HN, Burger PJ, Corrigan BW, et al. Population pharmacokinetic (PK) analyses of pregabalin (PGB) in adult patients with refractory partial seizures [abstract 1.265]. Epilepsia. 2001;42(Suppl 7):84.
7. Bockbrader HN, Burger P, Knapp L, Corrigan BW. Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. Epilepsia. 2011;52:248-57.
8. Shoji S, Suzuki M, Tomono Y, et al. Population pharmacokinetics of pregabalin in healthy subjects and patients with postherpetic neuralgia or diabetic peripheral neuropathy. Br J Clin Pharmacol. 2011;72:63-76.
9. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia. 2004;45(Suppl 6):13-8.
10. Brodie MJ, Wilson EA, Wesche DL, et al. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia. 2005;46:1407-13.
11. Bockbrader HN, Burger P, Knapp L. Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. Epilepsia. 2011;52:405-9.
12. Srivastava K, Arora A, Kataria A, et al. Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence. 2013;7: 419-34.
13. Alebic-Kolbah T. Pregabalin: development and validation of an LC-MS/MS method for pediatric studies [abstract TP 542]. J Am Soc Mass Spectrom. 2012;23:109.
14. Kellow JE, Borody TJ, Phillips SF, et al. Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology. 1986;91:386-95.
15. Kumar D, Wingate D, Ruckebusch Y. Circadian variation in the propagation velocity of the migrating motor complex. Gastroenterology. 1986;91:926-30.
16. Wilson P, Perdikis G, Hinder RA, et al. Prolonged ambulatory antroduodenal manometry in humans. Am J Gastroenterol. 1994;89:1489-95.
17. Soffer EE, Thongsawat S, Ellerbroek S. Prolonged ambulatory duodeno-jejunal manometry in humans: normal values and gender effect. Am J Gastroenterol. 1998;93:1318-23.
18. Beydoun A, Uthman BM, Kugler AR, The Pregabalin 1008-009 Study Group, et al. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology. 2005;64:475-80.
19. Pohl RB, Feltner DE, Fieve RR, Pande AC. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing. J Clin Psychopharmacol. 2005;25:151-8.
20. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care. 2008;31:1448-54.
21. Frampton JE, Foster RH. Pregabalin: in the treatment of postherpetic neuralgia. Drugs. 2005;65:111-20.
22. Freynhagen R, Serpell M, Emir B, et al. A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain. Pain Pract. 2013;. doi:10.1111/papr.12146.
23. French J, Brandt C, Friedman D, et al. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial. Epilepsia. 2014;. doi:10.1111/epi.12690.
24. Arnold LM, Arsenault P, Huffman C, et al. Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study. Curr Med Res Opin. 2014;. doi:10.1185/03007995.2014.928275.
25. Chew ML, Plotka A, Alvey CW, et al. Pharmacokinetics of Pregabalin Controlled-Released in Healthy Volunteers: Effect of Food in Five Single-Dose, Randomized, Clinical Pharmacology Studies. Clin Drug Investig. 2014;. doi:10.1007/s40261-014-0211-4